Base-matching or so-called mini-sequencing is a powerful technique for genotyping and mutation identification. However, its application is often hampered by high background and high cost. We have decreased the background by ∼5-fold by incorporating an endblocking step and using only 1/10 of the usual nucleotide concentrations.
Precise determination of a genotype or identification of a point mutation is often carried out by an assay in which the interrogated base is revealed after it is matched with a known complementary dideoxynucleotide. This single-base primer extension, or basematching, is referred to as mini-sequencing or primer guidenucleotide incorporation (1, 2) . The assay uses the polymerase chain reaction (PCR) (3) for generating template molecules in a sufficient number and the Sanger sequencing reaction (4) for incorporating a single complementary fluorescent dideoxynucleotide into a template-probe hybrid.
In a typical base-matching assay (5), single-stranded and biotin-labeled molecules of template DNA generated by PCR are first immobilized on a streptavidin-coated solid support. A specific oligonucleotide (probe) is then hybridized to the immobilized DNA. The base in the template DNA that immediately follows the 3′-end of the probe is then identified after extending the probe sequence with a complementary dye-conjugated dideoxynucleotide. However, the signal is often confounded by a high background that is likely to have resulted from non-specific extension at the 3′-end of the biotinylated sequences involved in secondary structures, or from extension of probe molecules in non-specific sites. Our modified procedure, which incorporates a blocking step and low nucleotide concentrations, solves the background problem. We describe the refined procedure and its application in detection of mutations related to sickle cell disease.
The procedure that we have been using is as follows: 1. Perform PCR with a 5′ biotin-labeled primer and a normal 3′ primer under standard conditions. A clear band should be seen by analyzing 5 µl of the PCR product on an agarose gel. Dilute an aliquot of the amplified DNA 1:50 in Binding Buffer (5× SSC, 8% formamide, 8% Triton X-100, 1 mg/ml BSA). 2. Wash a streptavidin-coated well (either low or high capacity in an 8-well strip; Boehringer Mannheim) once with the Binding Buffer; add 20 µl of the diluted sample to the well; incubate the solution at 37¡C for 15 min. The introduction of a blocking step (Step 5) and the use of low concentrations of nucleotides are designed to reduce background. To demonstrate the effects of these modifications, we assayed DNA obtained from the normal human adult beta-globin gene sequence (A-gene) and the S variant gene sequence (S-gene) (6, 7) . Independent amplifications were performed on each of these DNAs using the same primer set (5GNB: Biotin 5′-tgt gga gcc aca ccc tag ggt tg-3′ and 3CBM: 5′-ctt gcc atg agc ctt cac att agg-3′). Probe AC (5′-ggc agt aac ggc aga ctt ctc ct-3′) and F-ddCTP were used to interrogate for the first base, G, of the 6th codon in the A-gene (A-codon). Probe ACS (5′-ggc agt aac ggc aga ctt ctc c-3′) and F-ddATP were used to interrogate for the second base, T, of the 6th codon in the S-gene (S-codon). A positive test, defined as an assay in which the A-gene sequence was assayed for 'A-codon' or the S-gene sequence for 'S-codon', was expected to produce a higher O.D. reading than when, for example, the A gene sequence was interrogated for the presence of the S-codon (negative test). Therefore, the O.D. reading derived from a negative test defined the background value for the corresponding positive test.
*To whom correspondence should be addressed. Tel: +1 617 983 6351; Fax: +1 617 522 2846; Email: xsu@world.std.com Figure 1 shows that when the blocking step was incorporated into the published protocol (5), the background dropped 2-3-fold. Lowering nucleotide concentrations to 1/10 of the published concentrations (5) reduced the background further. Using both modifications, we were able to decrease the background significantly, resulting in a 5-fold increase in the signal/background ratio. Relatively higher backgrounds in positive tests for A-gene (as compared to positive tests for S-gene) suggest that other factors may contribute, but the present modifications diminish the backgrounds to an acceptably low level.
By preventing non-specific extension, while preserving sensitivity, we significantly enhance the signal-to-background ratio in the base-matching assay. Such high specificity is critical to the use of such an assay in clinical applications. An added benefit is the significant cost savings by the use of substantially less dideoxynucleotides. Together, these improvements make this assay attractive for large scale diagnosis of genetic diseases.
